Recorded Webinar (45 min)

 

Artificial Intelligence: How effective is it for pharma pricing & forecasting? Some evidence-based answers
↓ Watch the recorded webinar below:

 

Artificial intelligence (AI) - “getting computers to do things that normally require a human mind” - is routinely being put to good use when making pharma clinical development decisions. But how effective is it for informing pharma pricing and forecasting decisions? Too often AI is being used without credible evidence or real-world validation.

Learn how to avoid the bear traps and how to get the most from your big data:

Understand why AI is not living up to its expectations
Three useful checks before using AI
How to ensure you are using the right approach

With Gary Johnson

gary_2019.png

  • Faculty member of CELforPharma since 2007, teaching the popular 2-day courses The Pharma Forecasting Course and Value Pricing for Optimising Market Access.
  • Founder & Chairman of Inpharmation, Europe's most respected pharma forecasting & pricing specialist consultancy.
  • Has been involved in the pricing and/or forecasting of around half of the new molecular entity launches over the past five years.
  • Author of Sales Forecasting for Pharmaceuticals: An Evidence Based Approach and Value Pricing for Market Access: Evidence-Based Pricing for Pharmaceuticals.

 

↓ Submit your contact details to watch the recorded webinar: